摘要
An international research team with multi-discipline expertise directed by Prof.Cui Rutao(major in biology)at the School of Medicine Boston University,Prof.Deng XianMing(邓贤明,major in medicinal chemistry)at the School of Life Sciences,Xiamen University,and Prof.Wang Peng(王鹏,major in clinical research)at Shanghai Cancer Center,Fudan University,recently reported a novel and viabletherapeutic strategy for melanomas harboring NRAS mutations.
